Document is current
Any future updates will be listed below
-
Authors
Brestoff, Jonathan R. https://orcid.org/0000-0002-7018-7400
Singh, Keshav K. https://orcid.org/0000-0002-0047-8616
Aquilano, Katia https://orcid.org/0000-0002-5905-9870
Becker, Lance B.
Berridge, Michael V. https://orcid.org/0000-0003-2619-7473
Boilard, Eric https://orcid.org/0000-0001-6319-6432
Caicedo, Andrés https://orcid.org/0000-0001-8821-0333
Crewe, Clair https://orcid.org/0000-0002-3117-5327
Enríquez, José Antonio https://orcid.org/0000-0002-3671-2961
Gao, Jianqing https://orcid.org/0000-0003-1052-7060
Gustafsson, Åsa B.
Hayakawa, Kazuhide
Khoury, Maroun https://orcid.org/0000-0002-9965-6266
Lee, Yun-Sil https://orcid.org/0000-0002-1228-0404
Lettieri-Barbato, Daniele
Luz-Crawford, Patricia
McBride, Heidi M.
McCully, James D. https://orcid.org/0000-0003-1058-6976
Nakai, Ritsuko https://orcid.org/0000-0002-7891-4879
Neuzil, Jiri
Picard, Martin
Rabchevsky, Alexander G.
Rodriguez, Anne-Marie https://orcid.org/0000-0001-5557-8975
Sengupta, Shiladitya
Sercel, Alexander J. https://orcid.org/0000-0002-0749-2162
Suda, Toshio https://orcid.org/0000-0001-7540-1771
Teitell, Michael A. https://orcid.org/0000-0002-4495-8750
Thierry, Alain R.
Tian, Rong https://orcid.org/0000-0002-3676-3830
Walker, Melanie https://orcid.org/0000-0002-8995-4657
Zheng, Minghao https://orcid.org/0000-0003-1185-4768
-
Funding
Funding for this research was provided by:
Burroughs Wellcome Fund (CAMS #1019648)
- License Information
-
More Information
Article History
Received: 27 August 2024
Accepted: 5 December 2024
First Online: 16 January 2025
Competing interests
: J.R.B. is a member of the Scientific Advisory Board of LUCA Science, Inc.; receives research support from LUCA Science and Edgewise Therapeutics; is a consultant for Columbus Instruments, Inc.; has consulted for DeciBio within the past 12 months; receives royalties from Springer Nature Group; is an inventor on technology licensed to Columbus Instruments, Inc. with royalty rights; is an inventor on pending patent applications related to the treatment of metabolic diseases (63/625,555) and allergic diseases (US20210128689A1) and mitochondria transfer (018984/US); and is a co-founder and holds equity in Symbiogenix, Inc. K.K.S. is a co-founder, holds equity in, and serves on the Scientific Advisory Board for YUVA Biosciences. E.B. holds patents on detection of extracellular mitochondria in inflammatory conditions (WO2015051466A1) and on mitochondrial autoantibodies in autoimmune diseases (WO2022/246565A1), and is a principal investigator and scientific advisor to MitrixBio. L.B. receives grant support from Philips Medical Systems, ZOLL Medical Corp, Nihon Kohden, PCORI, BrainCool and United Therapeutics; is on the Scientific Advisory Board for Nihon Kohden, HP and Philips; holds seven issued patents and several pending patent applications involving the use of medical slurries as human coolant devices, the creation of slurries, reperfusion cocktails, and measurement of respiratory quotient; and serves on committees for the American Heart Association, which has a financial interest in the outcome of resuscitation studies being conducted and that sells training materials worldwide on resuscitation techniques. A.C. is a founder of and scientific advisor to Dragon Biomed and a scientific advisor to Luvigix. J.A.E. has collaborated with Minova Therapeutics. Å.B.G. is a consultant for Lexeo Therapeutics. J.D.M. has pending patents for the isolation and use of isolated mitochondria and is a founder and member of the Scientific Advisory Board and Board of Directors for cellvie. M.K. is the chief scientific officer of Cells for Cells, EVast Bio, and Regenero (Chilean consortium for regenerative medicine) with Corporación de Fomento de la Producción support; has received research support from ANID (National Agency for Research and Development) basal and Cells for Cells; is an inventor on patents related to mesenchymal stem cells (pending patents WO2014135924A1, WO20170646770A2, WO2017064672A1 and WO2019051623). R.N. receives research support from LUCA Science, Inc. A.J.S. is an employee of MitoWorld. M.A.T. is a co-founder and shareholder for NanoCav, a private start-up company with licences for mitochondria-transfer techniques and applications. A.R.T. is an inventor of a pending patent related to the diagnostic detection of cf-mtDNA (WO 2016/063122 A1). R.T. is a scientific advisor for Cytokinetics, Inc. and GenKardia, Inc. M.W. has a pending patent (US20210085713A1) related to compositions and methods for treating stroke. The other authors declare no competing interests.
Free to read: This content has been made available to all.
